Association of Self-Reported COVID-19 Vaccination Status with COVID-19 Infection Among Adult Long-Term Hematopoietic Cell Transplantation Survivors
The coronavirus disease 2019 (COVID-19) pandemic has caused over 100 million infections and over 1 million deaths in the United States (US).1 Hematopoietic cell transplantation (HCT) recipients are at increased risk of severe disease and adverse outcomes from COVID-19 infection, with reported mortality rates between 17-40%.2 –6 Older age, male sex, development of COVID-19 infection within 12 months of HCT, active graft-versus-host disease (GVHD), and steroid use are risk factors for worse outcomes.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Emily C. Liang, Lynn E. Onstad, Paul Carpenter, Steven A. Pergam, Mary E. Flowers, Stephanie J. Lee, Catherine Liu Source Type: research
More News: Biology | Coronavirus | Covid Vaccine | COVID-19 | Hematology | Pandemics | Transplants | USA Health | Vaccines